Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Salmonella enterica serovar Enteritidis O-antigen polysaccharide is a highly variable, surface-exposed carbohydrate polymer that constitutes the O-antigen portion of the lipopolysaccharide (LPS) layer found on the outer membrane of Gram-negative bacteria. Structurally, it is a repeating oligosaccharide chain with a specific serovar-defining composition: in Enteritidis, the backbone consists of mannose, rhamnose, and galactose, plus a distinctive tyvelose sugar that confers serovar specificity (O:9 antigen). Genetic diversity and post-assembly modifications (e.g., glucosylation, acetylation) further alter immunogenicity and serotype features. The O-antigen is a potent virulence factor, enabling resistance to complement-mediated killing, masking other immunogenic surface structures, and aiding environmental persistence and transmission. It is the primary antigenic determinant for Salmonella serotyping and a main candidate for vaccine development, with O-antigen-protein conjugates and GMMA-based systems under investigation for broad, cross-serovar protection. The heterogeneity and immune-modulatory roles of the O-antigen make it both a valuable therapeutic target and a persistent challenge in bacterial vaccine design.
Induction of opsonophagocytic antibodies facilitating immune recognition and clearance of Salmonella Neutralization of polysaccharide antigen via antibody binding Elicitation of cross-protective immunity across serovars
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salmonella enterica serovar Enteritidis O-antigen polysaccharide (None commonly used; sometimes referred to as O-Ag or O-antigen, but these are generic terms).